Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study

por Tatsuoka, Yoshihisa, Takeshima, Takao, Ozeki, Akichika, Matsumura, Taka
Publicado 2021

Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial

por Takeshima, Takao, Komori, Mika, Tanji, Yuka, Ozeki, Akichika, Tatsuoka, Yoshihisa
Publicado 2022

A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults

por Sakai, Fumihiko, Takeshima, Takao, Tatsuoka, Yoshihisa, Hirata, Koichi, Lenz, Robert, Wang, Yi, Cheng, Sunfa, Hirama, Toshiyasu, Mikol, Daniel D.
Publicado 2019

Long‐term efficacy and safety during open‐label erenumab treatment in Japanese patients with episodic migraine

por Sakai, Fumihiko, Takeshima, Takao, Tatsuoka, Yoshihisa, Hirata, Koichi, Cheng, Sunfa, Numachi, Yotaro, Peng, Cheng, Xue, Fei, Mikol, Daniel D.
Publicado 2021

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patient...

por Sakai, Fumihiko, Suzuki, Norihiro, Kim, Byung‐Kun, Tatsuoka, Yoshihisa, Imai, Noboru, Ning, Xiaoping, Ishida, Miki, Nagano, Kaori, Iba, Katsuhiro, Kondo, Hiroyuki, Koga, Nobuyuki
Publicado 2021

Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double‐blind, placebo‐controlled studies

por Hirata, Koichi, Takeshima, Takao, Sakai, Fumihiko, Imai, Noboru, Matsumori, Yasuhiko, Tatsuoka, Yoshihisa, Numachi, Yotaro, Yoshida, Ryuji, Peng, Cheng, Mikol, Daniel D., Lima, Gabriel Paiva da Silva, Cheng, Sunfa
Publicado 2022